Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Market Analysis and Insights: Global Intravenous (IV) Ibuprofen Market
In 2020, the global Intravenous (IV) Ibuprofen market size was US$ 7046.7 million and it is expected to reach US$ 15400 million by the end of 2027, with a CAGR of 11.3% between 2021 and 2027
Global Intravenous (IV) Ibuprofen Scope and Market Size
The global Intravenous (IV) Ibuprofen market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.
Segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Segment by Application
Pain
Fever
Inflammation
By Company
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Intravenous (IV) Ibuprofen Market
In 2020, the global Intravenous (IV) Ibuprofen market size was US$ 7046.7 million and it is expected to reach US$ 15400 million by the end of 2027, with a CAGR of 11.3% between 2021 and 2027
Global Intravenous (IV) Ibuprofen Scope and Market Size
The global Intravenous (IV) Ibuprofen market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.
Segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Segment by Application
Pain
Fever
Inflammation
By Company
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.